Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 1, 2023
0Patent Application Number
171193050
Date Filed
December 11, 2020
0Patent Citations
...
Patent Citations Received
Patent Primary Examiner
Provided herein is a pharmaceutical composition comprising an effective amount of cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301), cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Tyr-OH (LS838) or pharmaceutically acceptable salts thereof, wherein each amino acid residue is independently in a D or L configuration; a divalent metal ion; and a pharmaceutically acceptable carrier. Further provided are lyophilized products comprising a dye-conjugate and m methods for identifying compromised and for binding phosphorylated annexin A2 (pANXA2) protein in a biological sample using a composition described herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.